BOSTON SCIENTIFIC CORP — Director's Dealing 2021

Aug 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-08-02

Reporting Person: Eddy Jodi Euerle (SVP, Chief Info & Digital Off.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-02	Common Stock	S	727.0000	$45.7700	Disposed	20050.0000	Direct
2021-08-03	Common Stock	M	1973.0000	$0.0000	Acquired	22023.0000	Direct
2021-08-03	Common Stock	F	876.0000	$45.5400	Disposed	21147.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-03	Deferred Stock Units	$	M	1973.0000	Disposed	2024-08-03	Common Stock (1973.0000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F3: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 3, 2021, the first anniversary of the date of grant.